Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
26.31
-1.10 (-4.01%)
At close: Jul 18, 2025, 4:00 PM
26.25
-0.06 (-0.23%)
After-hours: Jul 18, 2025, 7:56 PM EDT

Ultragenyx Pharmaceutical Statistics

Total Valuation

RARE has a market cap or net worth of $2.48 billion. The enterprise value is $2.81 billion.

Market Cap2.48B
Enterprise Value 2.81B

Important Dates

The next estimated earnings date is Thursday, July 31, 2025, after market close.

Earnings Date Jul 31, 2025
Ex-Dividend Date n/a

Share Statistics

RARE has 94.38 million shares outstanding. The number of shares has increased by 21.44% in one year.

Current Share Class 94.38M
Shares Outstanding 94.38M
Shares Change (YoY) +21.44%
Shares Change (QoQ) +0.63%
Owned by Insiders (%) 3.56%
Owned by Institutions (%) 97.34%
Float 90.98M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 4.17
Forward PS 3.55
PB Ratio 17.10
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 4.76
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.40, with a Debt / Equity ratio of 5.88.

Current Ratio 2.40
Quick Ratio 2.05
Debt / Equity 5.88
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -8.35

Financial Efficiency

Return on equity (ROE) is -377.06% and return on invested capital (ROIC) is -30.38%.

Return on Equity (ROE) -377.06%
Return on Assets (ROA) -24.51%
Return on Invested Capital (ROIC) -30.38%
Return on Capital Employed (ROCE) -50.34%
Revenue Per Employee $456,483
Profits Per Employee -$424,713
Employee Count1,294
Asset Turnover 0.45
Inventory Turnover 18.87

Taxes

In the past 12 months, RARE has paid $2.45 million in taxes.

Income Tax 2.45M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -40.05% in the last 52 weeks. The beta is 0.26, so RARE's price volatility has been lower than the market average.

Beta (5Y) 0.26
52-Week Price Change -40.05%
50-Day Moving Average 35.51
200-Day Moving Average 41.98
Relative Strength Index (RSI) 26.20
Average Volume (20 Days) 2,632,782

Short Selling Information

The latest short interest is 6.82 million, so 7.23% of the outstanding shares have been sold short.

Short Interest 6.82M
Short Previous Month 6.08M
Short % of Shares Out 7.23%
Short % of Float 7.50%
Short Ratio (days to cover) 5.87

Income Statement

In the last 12 months, RARE had revenue of $590.69 million and -$549.58 million in losses. Loss per share was -$5.88.

Revenue590.69M
Gross Profit -182.32M
Operating Income -513.57M
Pretax Income -586.86M
Net Income -549.58M
EBITDA -477.88M
EBIT -513.57M
Loss Per Share -$5.88
Full Income Statement

Balance Sheet

The company has $494.44 million in cash and $889.70 million in debt, giving a net cash position of -$326.69 million or -$3.46 per share.

Cash & Cash Equivalents 494.44M
Total Debt 889.70M
Net Cash -326.69M
Net Cash Per Share -$3.46
Equity (Book Value) 151.25M
Book Value Per Share 1.54
Working Capital 407.49M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$389.94 million and capital expenditures -$5.60 million, giving a free cash flow of -$395.54 million.

Operating Cash Flow -389.94M
Capital Expenditures -5.60M
Free Cash Flow -395.54M
FCF Per Share -$4.19
Full Cash Flow Statement

Margins

Gross margin is -30.87%, with operating and profit margins of -86.94% and -93.04%.

Gross Margin -30.87%
Operating Margin -86.94%
Pretax Margin -92.63%
Profit Margin -93.04%
EBITDA Margin -80.90%
EBIT Margin -86.94%
FCF Margin n/a

Dividends & Yields

RARE does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -21.44%
Shareholder Yield -21.44%
Earnings Yield -22.13%
FCF Yield -15.93%
Dividend Details

Analyst Forecast

The average price target for RARE is $87.40, which is 232.19% higher than the current price. The consensus rating is "Strong Buy".

Price Target $87.40
Price Target Difference 232.19%
Analyst Consensus Strong Buy
Analyst Count 15
Revenue Growth Forecast (5Y) 35.12%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

RARE has an Altman Z-Score of -2.69 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -2.69
Piotroski F-Score 4